These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 6368413

  • 1. Reversal reaction in lepromatous patients induced by a vaccine containing killed ICRC bacilli--a report of five cases.
    Bhatki WS, Chulawala RG, Bapat CV, Deo MG.
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):466-72. PubMed ID: 6368413
    [Abstract] [Full Text] [Related]

  • 2. Potential anti-leprosy vaccine from killed ICRC bacilli--a clinicopathological study.
    Deo MG, Bapat CV, Chullawalla RG, Bhatki WS.
    Indian J Med Res; 1981 Aug; 74():164-77. PubMed ID: 7030942
    [No Abstract] [Full Text] [Related]

  • 3. Effects of ICRC antileprosy vaccine in healthy subjects.
    Chaturvedi RM, Chirmule NB, Yellapurkar MV, Shaikh SU, Deo MG.
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):657-66. PubMed ID: 3323368
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules.
    Bapat CV, Modak MS, DeSouza NG, Chulawalla RG.
    Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823
    [Abstract] [Full Text] [Related]

  • 6. Pilot study to determine acceptability and ability of heat-killed Mycobacterium leprae plus BCG (HKML+BCG) vaccine to induce skin test conversion.
    Chen ZL, Tang QG, Wang ZM, Chen J.
    Lepr Rev; 1993 Jun; 64(2):117-27. PubMed ID: 8341114
    [Abstract] [Full Text] [Related]

  • 7. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
    Gupte MD, Anantharaman DS, De Britto RL, Vallishayee RS, Nagaraju B, Kannan S, Sengupta U.
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
    [Abstract] [Full Text] [Related]

  • 8. Immunological properties of M. leprae culture isolates ICRC bacilli: hypothesis on relationship between M. leprae and ML-culture isolates.
    Bapat CV.
    Acta Leprol; 1984 Sep; 2(2-4):175-94. PubMed ID: 6442820
    [Abstract] [Full Text] [Related]

  • 9. Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study.
    Wakhlu A, Gaur SP, Kaushal GP, Misra A, Asthana P, Sircar AR.
    Lepr Rev; 2001 Jun; 72(2):179-91. PubMed ID: 11495449
    [Abstract] [Full Text] [Related]

  • 10. Immunogenic "subunit" of the ICRC antileprosy vaccine.
    Chirmule NB, Chaturvedi RM, Deo MG.
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):27-35. PubMed ID: 3131465
    [Abstract] [Full Text] [Related]

  • 11. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
    Majumder V, Mukerjee A, Hajra SK, Saha B, Saha K.
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
    Chaudhury S, Hazra SK, Saha B, Mazumder B, Biswas PC, Chattopadhya D, Saha K.
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911
    [Abstract] [Full Text] [Related]

  • 14. Lepromin conversion induced by a 'sub-unit' vaccine from ICRC bacilli.
    Bhatki WS, Chullawala RG, Chaturvedi RM, Dixit GM, Deo MG.
    Indian J Med Res; 1988 Jun; 87():545-54. PubMed ID: 3071521
    [No Abstract] [Full Text] [Related]

  • 15. ICRC 'anti-leprosy vaccine'.
    Deo MG.
    Vaccine; 1989 Apr; 7(2):92-3. PubMed ID: 2665352
    [Abstract] [Full Text] [Related]

  • 16. Human vaccination studies in normal and contacts of leprosy patients.
    Samuel NM, Stanford JL, Rees RJ, Fairbairn T, Adiga RB.
    Indian J Lepr; 1984 Apr; 56(1):36-47. PubMed ID: 6384380
    [No Abstract] [Full Text] [Related]

  • 17. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
    Chaudhury S, Hajra SK, Mukerjee A, Saha B, Majumdar V, Chattapadhya D, Saha K.
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
    [Abstract] [Full Text] [Related]

  • 18. Sensitization and reactogenicity of two doses of candidate antileprosy vaccine Mycobacterium w.
    Gupte MD, Vallishayee RS, Anantharaman DS, Britto RL, Nagaraju B.
    Indian J Lepr; 1996 Mar; 68(4):315-24. PubMed ID: 9001899
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.